parthenolide has been researched along with Bladder Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appaiah, H; Cheng, L; Crooks, P; Klaunig, J; Kusumanchi, P; Matthews, W; Nakshatri, H; Neelakantan, S; Peat, T; Shanmugam, R; Sweeney, CJ | 1 |
Cheng, G; Xie, L | 1 |
2 other study(ies) available for parthenolide and Bladder Cancer
Article | Year |
---|---|
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species.
Topics: Animals; Base Sequence; Carcinogens; Cell Cycle; Cell Division; DNA Primers; Electrophoretic Mobility Shift Assay; Flow Cytometry; Lung Neoplasms; Male; Mice; Mice, Nude; NF-kappa B; Nicotiana; Nitrosamines; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sesquiterpenes; Urinary Bladder Neoplasms | 2011 |
Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 2; Diffusion Chambers, Culture; Flow Cytometry; G1 Phase; Humans; Microscopy; Neoplasm Invasiveness; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Signal Transduction; Tanacetum parthenium; Urinary Bladder Neoplasms | 2011 |